血液透析联合血液灌流在维持性血液透析患者钙磷代谢紊乱治疗中的应用评价

在线阅读 下载PDF 导出详情
摘要   【摘 要】目的:探讨分析血液透析联合血液灌流在维持性血液透析患者钙磷代谢紊乱治疗中的应用效果。方法:从 2018年 1月~ 2019年 4月于我院收治的血液透析患者病例中,选取 80例作为研究对象,随机分为实验组( 40例)和常规组( 40例),其中,行常规血液透析治疗为常规组患者,行血液透析联合血液灌流治疗为实验组,对两组患者治疗后的血磷含量、血钙含量、血尿素氮等进行对比和分析。结果:在治疗后,实验组的血磷含量、血尿素氮等,明显低于常规组,但是实验组的血钙含量高于常规组,对比差异显著( P<0.05)。结论:在维持性血液透析患者治疗中,血液透析联合血液灌流具有显著的应用价值,可以对患者的钙磷代谢紊乱症状予以有效改善。    【关键词】血液透析 ;血液灌流 ;维持性血液透析 ;钙磷代谢紊乱  [Abstract] Objective: To explore the effect of hemodialysis combined with hemoperfusion in the treatment of calcium and phosphorus metabolism disorder in maintenance hemodialysis patients. Methods: from January 2018 to April 2019, 80 hemodialysis patients in our hospital were randomly divided into the experimental group (40 cases) and the conventional group (40 cases). Among them, the patients in the conventional group were treated with conventional hemodialysis and the patients in the experimental group were treated with hemodialysis combined with hemoperfusion. The blood phosphorus content, blood calcium content and hematuria of the two groups after treatment were measured Nitrogen and other elements were compared and analyzed. Results: after treatment, the blood phosphorus content and blood urea nitrogen in the experimental group were significantly lower than those in the conventional group, but the blood calcium content in the experimental group was significantly higher than that in the conventional group (P < 0.05). Conclusion: in the treatment of maintenance hemodialysis patients, hemodialysis combined with hemoperfusion has significant application value, which can effectively improve the symptoms of calcium and phosphorus metabolism disorder.
出处 《中华医学信息导报》 2020年08期
关键词
出版日期 2020年08月11日(中国期刊网平台首次上网日期,不代表论文的发表时间)